Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Dividend & Equity Income · Morgan Stanley

Eaton Vance Dividend Builder Fund Eaton Vance Dividend Builder Fund Class C (ECTMX)

Ticker ECTMX · · Holdings as of Jun 30, 2026

Expense ratio
1.75%$175/yr per $10k
5-yr return
+8.4%annualized
1-yr return
+6.7%as of Dec 2025
Net assets
$914.2Mall share classes
Holdings
58

Bottom line

Is ECTMX a good fund? The bottom line

ECTMX is a share class of Eaton Vance Dividend Builder Fund, a managed dividend & equity income mutual fund from Morgan Stanley.

It charges 1.75% — about $175 a year on every $10,000 invested, more expensive than 93% of dividend & equity income funds we track.

It returned +6.7% over one year, +8.4% a year over five years, +10.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $914 million in net assets and 58 holdings, its largest position is Broadcom Inc (4.0%) and the top 10 make up 29.3% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.75%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What ECTMX invests in

The Funds investment objective is to seek total return.

Under normal market conditions, the Fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in dividend-paying common stocks and dividend-paying or interest-bearing securities that are convertible into common stock (the 80% Policy). Dividend-paying securities are securities that periodically pay, or are expected to pay, interest or dividends (which are payments of earnings from a company). The Fund invests primarily in large-cap stocks but may invest in companies with a broad range of market capitalizations, including smaller companies. The Fund may invest up to 20% of its net assets in fixed-income securities, including (with respect to up to ?10% of its net assets) securities rated BBB by S&P Global Ratings (S&P) or Baa by Moodys Investors Service, Inc. (Moodys) or below and unrated securities determined by the investment adviser to be of comparable…

From the fund's prospectus (filed Oct 5, 2026).

ECTMX performance

Average annual total returns
1 yr5 yr10 yr
ECTMX+6.7%+8.4%+10.0%
Dividend & Equity Income median+14.6%+10.1%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full ECTMX performance history →

What ECTMX costs

On a $10,000 investment, ECTMX's 1.75% expense ratio costs about $175 a year. The prospectus estimates $1,864 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.

See the full ECTMX fee table →

ECTMX top 10 holdings

#Holding% of fund
1Broadcom Inc4.00%
2JPMorgan Chase & Co3.73%
3UnitedHealth Group Inc3.25%
4Coca-Cola Co/The3.23%
5Johnson & Johnson2.61%
6Chevron Corp2.60%
7KLA Corp2.52%
8AbbVie Inc2.49%
9Lam Research Corp2.46%
10Cisco Systems Inc2.43%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 29.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to ECTMX

More funds like ECTMX →

ECTMX FAQ

What is the expense ratio of ECTMX?
ECTMX's expense ratio is 1.75%, which works out to about $175 a year for every $10,000 invested. The prospectus estimates total costs of $1,864 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ECTMX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.75%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does ECTMX hold?
ECTMX's largest holdings are Broadcom Inc (4.0%), JPMorgan Chase & Co (3.7%), UnitedHealth Group Inc (3.3%), Coca-Cola Co/The (3.2%), Johnson & Johnson (2.6%). It holds 58 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is ECTMX's 5-year return?
ECTMX returned +8.4% a year over the five years ending Dec 31, 2025, and +10.0% a year over ten years. Past performance does not guarantee future results.
Does ECTMX have a sales load?
No. ECTMX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages ECTMX?
ECTMX is offered by Morgan Stanley through Eaton Vance Special Investment Trust.